Literature DB >> 2863616

Etidronate and the risk of fractures.

C Nagant de Deuxchaisnes, J P Dufour, J P Devogelaer, J P Huaux, W Esselinckx.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2863616     DOI： 10.1016/s0140-6736(85)90607-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Short term high doses of etidronate in Paget's disease of bone.

Authors:  J A Kanis; R E Gray; S A Murray; N A Hamdy; G H Urwin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

2.  Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).

Authors:  K S Eyres; P Marshall; E McCloskey; D L Douglas; J A Kanis
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

Review 3.  Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  C J Dunn; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.